These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The role of estradiol metabolites in prevention of cardiovascular diseases by hormone substitution in postmenopause]. Lippert TH; Seeger H; Mueck AO Zentralbl Gynakol; 1999; 121(10):467-72. PubMed ID: 10573819 [TBL] [Abstract][Full Text] [Related]
6. Effect of estrogen replacement therapy on lipids. Implications for cardiovascular risk. LaRosa JC J Reprod Med; 1985 Oct; 30(10 Suppl):811-3. PubMed ID: 4078813 [TBL] [Abstract][Full Text] [Related]
7. [Estrogens in menopause--therapy and prevention. III. Estrogen replacement in menopause: uses and risks in prevention and therapy of cardiovascular diseases]. Reincke M; Allolio B Internist (Berl); 1996 Apr; 37(4):410-5; discussion 415. PubMed ID: 8655282 [No Abstract] [Full Text] [Related]
8. Estrogen replacement therapy. Effect on blood pressure and other cardiovascular risk factors. Kaplan NM J Reprod Med; 1985 Oct; 30(10 Suppl):802-4. PubMed ID: 4078812 [TBL] [Abstract][Full Text] [Related]
9. [The story of the reversal of opinion about hormone replacement therapy and cardiovascular disease]. Løkkegaard EC Ugeskr Laeger; 2005 Mar; 167(10):1166-70. PubMed ID: 15810574 [No Abstract] [Full Text] [Related]
10. Estrogen use and cardiovascular disease. Henderson BE; Ross RK; Paganini-Hill A J Reprod Med; 1985 Oct; 30(10 Suppl):814-20. PubMed ID: 4078814 [TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of mental disorders in women during the climacteric period]. Tiushina NA; Balabanova VV; Balan VE Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(9):79-82. PubMed ID: 1664621 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of disorders of the climacteric by vaginal, rectal and transdermal estrogen substitution]. Lauritzen C Gynakologe; 1986 Dec; 19(4):248-53. PubMed ID: 3817597 [No Abstract] [Full Text] [Related]
13. Hormone replacement therapy and cardiovascular disease. McPherson R; Tardif JC; Jolly E Can J Cardiol; 2001 Nov; 17 Suppl D():32D-37D. PubMed ID: 11726994 [No Abstract] [Full Text] [Related]
14. Optimizing the dose of hormone replacement therapy. Rice VM Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707 [TBL] [Abstract][Full Text] [Related]
15. [Estrogen therapy in climacteric. Current views in an evidence-based perspective]. Nilsson K Lakartidningen; 2001 Jul; 98(28-29):3225-8. PubMed ID: 11496812 [TBL] [Abstract][Full Text] [Related]
16. [Low-dose estrogens in the treatment of the climacteric syndrome]. Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038 [TBL] [Abstract][Full Text] [Related]
17. [Oral hormone therapy in pre- and postmenopause]. Braendle W Med Klin (Munich); 1990 Apr; 85(4):200-5. PubMed ID: 2191210 [No Abstract] [Full Text] [Related]
18. [Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer]. Magnusson C; Weiderpass E Lakartidningen; 2001 Jan; 98(5):418-21. PubMed ID: 11229082 [TBL] [Abstract][Full Text] [Related]
19. [Hormone substitution by injectable preparations and skin implants]. Kuhl H Gynakologe; 1986 Dec; 19(4):241-7. PubMed ID: 3817596 [No Abstract] [Full Text] [Related]
20. Short-term results of transdermal estrogen replacement therapy in cardiovascular disease-free postmenopausal females with and without hypertension. Modena MG; Rossi R; Muia N; Origliani G; Rombolà O; Molinari R G Ital Cardiol; 1998 Jun; 28(6):636-44. PubMed ID: 9672776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]